Contrast Media Injectors Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Contrast Media Injector Manufacturers and the Market is Segmented by Product (Injector System and Consumables), Type of Injectors (Single-head Injectors, Dual-head Injectors, and Syringeless Injectors), Application (Radiology, Interventional Cardiology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market provides the value (in USD million) for the above segments.

Contrast Media Injectors Market Size

Contrast Media Injectors Market  Summary

Compare market size and growth of Contrast Media Injectors Market with other markets in Healthcare Industry

Contrast Media Injectors Market Analysis

The Contrast Media Injectors Market size is estimated at USD 1.96 billion in 2025, and is expected to reach USD 2.80 billion by 2030, at a CAGR of 7.44% during the forecast period (2025-2030).

The COVID-19 pandemic has had a devastating impact on the global population's health and a significant economic impact on most countries. The volume of imaging cases in many radiology departments dropped dramatically. The COVID-19 outbreak impacted patients' access to healthcare facilities as the pandemic forced them to wait for lifesaving imaging procedures. The pandemic also increased the waiting time for patients to have their imaging done. According to an article published by the Radiology Society of North America in April 2020, the COVID-19 pandemic profoundly impacted radiology practices across the country. The volume of diagnostic imaging and the number of CT and MRI machines installed will primarily determine the demand for CT Contrast Injectors. The easing of norms and the start of vaccination programs led to a recovery in the Contrast Injectors Market.

The major factors attributed to the growth of the Contrast Injectors Market are increasing demand for minimally invasive surgeries, technological advancements, and increasing regulatory approvals. Several advancements by Contrast Media Injector Manufacturers have been made to reduce contrast media waste and automate data collection regarding the dose received by a patient. For example, the automated injector systems precisely collect the amount of contrast media used. Vendors offer personalized doses to patients, using the information pulled from EMR or picture archiving and communication systems (PACS). One such advancement in reducing contrast media waste is the development of Smart Injectors, such as syringeless injectors.

According to the WHO updates from July 2021, cardiovascular diseases (CVDs) are the number one cause of death globally. An estimated 17.9 million each year suffer from cardiovascular diseases. Four out of five cardiovascular deaths are due to strokes and heart attacks, and one-third of deaths occur prematurely in people under 70 years. Similarly, according to the WHO 2021 fact sheet, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world. As per the same source, every year, over 15 million people aged between 30-69 years die due to NCDs across the world. Thus, due to the high burden of mortality due to NCDs, the demand for diagnostic procedures is increasing. As minimally invasive procedures have more advantages over traditional procedures, they are gaining traction, and thereby, the demand for Angiography Injectors is expected to increase.

Most companies are developing innovative products to reduce contrast media waste and gain a competitive advantage. Bracco has developed Smart Injectors, such as syringeless injectors, which can use every drop of contrast loaded into the system for maximum economy. Smart injectors record the amount injected and the imaging protocol used and send the information to the PACS. These constant technological advancements in Contrast Media Injector Technology are expected to boost the market during the forecast period.

However, the high cost of contrast media injectors and adverse effects of contrast agents are expected to plummet the growth of the market over the forecast period.

Contrast Media Injectors Industry Overview

The Contrast Media Injectors Market is consolidated, competitive, and consists of a few major players. In terms of market share, a few major players currently dominate the market. With increasing technological advancements, the high prevalence of diseases, and the increasing usage of minimally invasive surgeries, more companies are expected to enter the market in the coming years. Major Contrast Media Injector Manufacturers in the market are Bracco Group, GE Healthcare, Bayer HealthCare, Medtron AG, and Ulrich GmbH & Co. KG.

Contrast Media Injectors Market Leaders

  1. GE Healthcare (GE Company)

  2. Bracco Group

  3. Bayer AG

  4. Medtron AG

  5. Ulrich GmbH & Co. KG

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF

Contrast Media Injectors Market News

  • December 2021: Guerbet and Bracco Imaging announced a global collaboration for Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent.
  • December 2021: Qaelum NV announced a strategic partnership with Ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of Ulrich Medical to support the needs of hospitals and imaging networks.

Contrast Media Injectors Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Minimally Invasive Surgeries
    • 4.2.2 Technological Advancements and Increasing Number of Regulatory Approvals
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Contrast Media Injectors
    • 4.3.2 Adverse Effects of Contrast Agents
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Products
    • 5.1.1 Injector Systems
    • 5.1.1.1 CT Injector Systems
    • 5.1.1.2 MRI Injector Systems
    • 5.1.1.3 Cardiovascular/Angiography Injector Systems
    • 5.1.2 Consumables
    • 5.1.2.1 Tubing
    • 5.1.2.2 Syringe
    • 5.1.2.3 Other Consumables
  • 5.2 By Type of Injectors
    • 5.2.1 Single-head Injectors
    • 5.2.2 Dual-head Injectors
    • 5.2.3 Syringeless Injectors
  • 5.3 By Application
    • 5.3.1 Radiology
    • 5.3.2 Interventional Cardiology
    • 5.3.3 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bracco Group
    • 6.1.2 Guerbet Group
    • 6.1.3 Medtron AG
    • 6.1.4 Bayer HealthCare LLC
    • 6.1.5 ulrich GmbH & Co. KG
    • 6.1.6 Nemoto Kyorindo Co. Ltd
    • 6.1.7 GE Healthcare (GE Company)
    • 6.1.8 Hilin Life Products
    • 6.1.9 Sino Medical-Device Technology Co. Ltd
    • 6.1.10 APOLLO RT Co. Ltd
    • 6.1.11 Shenzen Seacrown Electromechanical Co. Ltd
    • 6.1.12 Shenzhen Anke High-tech Co. Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Contrast Media Injectors Industry Segmentation

Contrast media injectors (CMI) are devices employed for injecting contrast media into the body to improve the visibility of tissues for medical imaging procedures. The contrast media injectors market is segmented by Product (Injector System and Consumables), Type of Injectors (Single-head Injectors, Dual-head Injectors, and Syringeless Injectors), Application (Radiology, Interventional Cardiology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Products Injector Systems CT Injector Systems
MRI Injector Systems
Cardiovascular/Angiography Injector Systems
Consumables Tubing
Syringe
Other Consumables
By Type of Injectors Single-head Injectors
Dual-head Injectors
Syringeless Injectors
By Application Radiology
Interventional Cardiology
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Contrast Media Injectors Market Research FAQs

How big is the Contrast Media Injectors Market?

The Contrast Media Injectors Market size is expected to reach USD 1.96 billion in 2025 and grow at a CAGR of 7.44% to reach USD 2.80 billion by 2030.

What is the current Contrast Media Injectors Market size?

In 2025, the Contrast Media Injectors Market size is expected to reach USD 1.96 billion.

Who are the key players in Contrast Media Injectors Market?

GE Healthcare (GE Company), Bracco Group, Bayer AG, Medtron AG and Ulrich GmbH & Co. KG are the major companies operating in the Contrast Media Injectors Market.

Which is the fastest growing region in Contrast Media Injectors Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Contrast Media Injectors Market?

In 2025, the North America accounts for the largest market share in Contrast Media Injectors Market.

What years does this Contrast Media Injectors Market cover, and what was the market size in 2024?

In 2024, the Contrast Media Injectors Market size was estimated at USD 1.81 billion. The report covers the Contrast Media Injectors Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Contrast Media Injectors Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Contrast Media Injectors Industry Report

The report on the Global Contrast Media Injector Market provides a comprehensive industry analysis, focusing on the various segments by product, type of injectors, application, and geography. This industry report covers injector systems and consumables, highlighting the market trends and industry outlook for single-head injectors, dual-head injectors, and syringeless injectors. The market analysis includes applications in radiology, interventional cardiology, and other sectors, offering insights into market segmentation and market value.

The industry research delves into the market forecast, predicting growth rate and market growth across North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. This market report also provides an industry overview and market review, identifying market leaders and offering statistics on market size and industry size. The report example and free report PDF download provide detailed market data and industry statistics, essential for understanding the market predictions and market outlook.

The report includes a historical overview and a market forecast outlook, ensuring a thorough understanding of the market trends and industry information. Research companies can benefit from the detailed industry reports and industry sales data, which offer a clear perspective on the market forecast and market growth. The report also highlights the importance of market research and industry trends in shaping the future of the contrast media injectors market.

Contrast Media Injectors Market Report Snapshots

Contrast Media Injectors Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)